ClinicalTrials.Veeva

Menu
F

Florida Pharmaceutical Research and Associates | Miami, FL

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Amlitelimab
Molnupiravir

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 2 total trials

A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023) (MOVe-NOW)

Researchers are looking for other ways to prevent severe illness from COVID-19. COVID-19 is a virus that most often causes mild flu or cold-like symp...

Enrolling
Coronavirus Disease (COVID-19)
Drug: Placebo
Drug: Molnupiravir

This is a single group, 1-arm, long-term safety study for treatment of participants with moderate to severe atopic dermatitis (AD).The purpose of thi...

Enrolling
Dermatitis Atopic
Drug: Amlitelimab

Trial sponsors

Merck Sharp & Dohme (MSD) logo
Sanofi logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems